“We believe that single domain antibodies represent a promising new ... also obtained a favorable FDA review. The company also has a broad pipeline of wholly owned and worldwide patented sdAbs ...

Originally derived from camelid heavy chain antibodies, single domain or VHH antibodies can bind epitopes that are inaccessible to conventional monoclonal antibodies due to their small size. Because ...